The physicians of Connecticut Radiation Oncology strive to provide a caring environment for our cancer patients because we know that personal care is what matters the most. We work closely with our staff of board-certified radiation therapists and nurses to help make our patients' treatment experience as pleasant as possible.
Advanced Form Of Patient Care
For some types of cancers we offer treatment using a specialized machine called Cyberknife that delivers focused radiation with extreme accuracy in just a few visits. We are one of the most epxerienced Cyberknife center in the Northeast in providing this advanced cancer treatment for our patients.
Get In Touch For Help
Our center is set up in such a manner that it completely focuses on patient-centric solutions. We are here to provide the best treatment experience for our patients and their families. Learn about the full range of cancer treatments we offer. Feel free to get in touch with us.
About 1 in 9 men will be diagnosed with prostate cancer during their lifetime. About 6 cases in 10 are diagnosed in men who are 65 or older, and it is rare in men under 40. The average age at diagnosis is about 66.
Prognosis and treatment options depend on the stage of cancer when diagnosed. For cancers which have not spread, options depend on the PSA level (blood test) and the Gleason score from the biopsy.
Prognosis and treatment recommendations for prostate cancer which has not spread is related to the “risk group”.
Low risk cancer is defined as Gleason 6 cancer on biopsy, cancer is confined to the prostate gland, and PSA less than 10.
Intermediate risk cancer is defined as Gleason 7 cancer on biopsy, and/or PSA10-20, and cancer confined to the prostate.
High risk disease is defined as Gleason 8 or 9 on biopsy, and/or cancer extending outside of the prostate capsule, and/or PSA greater than 20.
The physicians of Connecticut Radiation Oncology are among a select few groups in the Northeast to offer three different radiation options for treatment of prostate cancer. In addition to offering IMRT/IGRT “daily” radiation, we also perform brachytherapy (radioactive seed implant) and CyberKnife stereotactic body radiation therapy (SBRT).
Treat prostate cancer in 5 simple treatments
Many prostate cancers can be treated in just five sessions over two weeks using the CyberKnife. Our group has pioneered the successful treatment of prostate cancer using the CyberKnife, with thousands of treatments performed since 2006. The advantage of the CyberKnife over other treatments is that it is non-invasive, convenient, with typically fewer side effects. Many reports, including our own, have demonstrated excellent long term cancer control for CyberKnife radiation in the treatment of low and intermediate risk prostate cancer. Recent studies also have demonstrated excellent results for selected patients with high risk prostate cancer.
To learn more about CyberKnife for prostate cancer, visit https://www.trinityhealthofne.org/location/radiation-oncology-at-saint-francis-hospital or www.cyberknife.com, or call The Connecticut CyberKnife Center at Saint Francis at (860) 714-4764.
Breast cancer is the most common cancer in women in the United States with the exception of skin cancer. About 1 in every 8 women will be diagnosed in their lifetime. Breast cancer treatment has rapidly evolved over the last 10 years. Many women can be treated with a shorter course of radiation compared to the past. In addition, treatments have become much more refined and focused, resulting in greatly reduced side effects and risks. Radiation therapy plays an important role in most breast cancer treatments. It is a form of cancer treatment that applies x-rays to the areas at risk of containing cancer cells. Our center is on the cutting edge of technology in Connecticut.
Our physicians use dedicated CT scans to precisely plan the optimal treatment for each breast cancer patient. We work closely with Breast Surgeons and Medical Oncologists to plan and customize care for optimal outcomes. We have been the leaders on Connecticut in offering hypofractionated radiation for breast cancer, whereby we can treat breast cancer with significantly fewer treatments and visits as compared to traditional techniques.
Lung cancer is the second most common cancer in men and women in the United States. The treatment of lung cancer has been rapidly evolving over the last decade. Our physicians offer a variety of highly targeted treatment options. 4D CT treatment planning is a technology that can track the movement of your cancer as you breath to precisely target the cancer while minimizing radiation exposure to your healthy lung and other surrounding organs.
Our physicians pioneered the use of CyberKnife stereotactic body radiation therapy (SBRT) in Connecticut. We have been using this breakthrough technology since 2006. It is an innovative form of intense focused radiation which can safely and effectively treat lung cancer in just 4 or 5 treatments over 1-2 weeks, with little, if any side effects. We work closely with Thoracic Surgeons, Pulmonary Physicians and Medical Oncologists to plan and customize care for each patient to provide the best treatment possible.
Radiation Treatment Options for Lung Cancer
Stage 1: CyberKnife Stereotactic Body Radiation Therapy (SBRT): 4-5 treatments over 1-2 weeks
Stages 2-3: Daily 3-D Conformal or Intensity Modulated Radiation Therapy (IMRT) radiation, 5 days per week over 6 weeks, often combined with chemotherapy and/or Immunotherapy” after chemotherapy.